Polypharm Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 22-06-2024
- Paid Up Capital ₹ 1.97 M
as on 22-06-2024
- Company Age 63 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 22-06-2024
- Satisfied Charges ₹ 3.18 M
as on 22-06-2024
- Revenue 17.14%
(FY 2022)
- Profit -4.94%
(FY 2022)
- Ebitda -5.28%
(FY 2022)
- Net Worth 18.26%
(FY 2022)
- Total Assets 11.81%
(FY 2022)
About Polypharm
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 1.97 M.
The company currently has active open charges totaling ₹2.00 M. The company has closed loans amounting to ₹3.18 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Gupta, Sheetal Gupta, and Sudha Gupta serve as directors at the Company.
- CIN/LLPIN
U24239MH1961PTC012054
- Company No.
012054
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 1961
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Polypharm Private Limited offer?
Polypharm Private Limited offers a wide range of products and services, including Dyes & Color Additives, White Pigments, Organic and Inorganic Solvents, Alcohol Solvents, Inorganic Salts, Magnesium Chloride, Swimming Pool & Water Sport Goods, Swimming Pool Chemicals, Industrial Chemicals & Supplies, Disinfectant Chemicals.
Who are the key members and board of directors at Polypharm?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Gupta  | Director | 04-Mar-1997 | Current |
| Sheetal Gupta | Director | 14-Oct-2021 | Current |
| Sudha Gupta | Director | 04-Mar-1997 | Current |
Financial Performance of Polypharm.
Polypharm Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.14% increase. The company also saw a slight decrease in profitability, with a 4.94% decrease in profit. The company's net worth Soared by an impressive increase of 18.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Polypharm?
In 2021, Polypharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gupta Commerce Pvt LtdActive 42 years 5 monthsPankaj Gupta, Sheetal Gupta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 25 Jan 2011 | ₹2.00 M | Open |
State Bank Of India Creation Date: 27 Jul 1988 | ₹2.90 M | Satisfied |
State Bank Of India Creation Date: 06 Jun 1981 | ₹0.14 M | Satisfied |
How Many Employees Work at Polypharm?
Polypharm has a workforce of 11 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polypharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polypharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
